Cargando…
Mechanism of action and therapeutic efficacy of Aurora kinase B inhibition in MYC overexpressing medulloblastoma
Medulloblastoma comprises four molecular subgroups of which Group 3 medulloblastoma is characterized by MYC amplification and MYC overexpression. Lymphoma cells expressing high levels of MYC are susceptible to apoptosis following treatment with inhibitors of mitosis. One of the key regulatory kinase...
Autores principales: | Diaz, Roberto Jose, Golbourn, Brian, Faria, Claudia, Picard, Daniel, Shih, David, Raynaud, Denis, Leadly, Michael, MacKenzie, Danielle, Bryant, Melissa, Bebenek, Matthew, Smith, Christian A., Taylor, Michael D., Huang, Annie, Rutka, James T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413659/ https://www.ncbi.nlm.nih.gov/pubmed/25739120 |
Ejemplares similares
-
Identification of alsterpaullone as a novel small molecule inhibitor to target group 3 medulloblastoma
por: Faria, Claudia C., et al.
Publicado: (2015) -
Thrombospondin-1 mimetics are promising novel therapeutics for MYC-associated medulloblastoma
por: Chan, Tiffany S Y, et al.
Publicado: (2021) -
MYC overexpression and SMARCA4 loss cooperate to drive medulloblastoma formation in mice
por: Göbel, Carolin, et al.
Publicado: (2023) -
ATRT-16. MODELLING ATRT THROUGH SWI/SNF COMPLEX DEFICIENCY IN GENETICALLY-ENGINEERED MOUSE MODELS
por: Bondoc, Andrew, et al.
Publicado: (2020) -
Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC
por: Lin, Zhong-Zhe, et al.
Publicado: (2010)